| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1122 | 27 | 1409 | 123 | 1498 | 221 | 1345 |
| ERLYTX | 77 | 2 | 104 | 9 | 110 | 16 | 97 |
| GI | 184 | 2 | 104 | 14 | 170 | 28 | 170 |
| GU | 371 | 5 | 261 | 19 | 231 | 50 | 304 |
| LEUK | 140 | 2 | 104 | 15 | 183 | 23 | 140 |
| LUNG | 199 | 2 | 104 | 25 | 304 | 44 | 268 |
| LYMPH | 393 | 7 | 365 | 39 | 475 | 74 | 450 |
| MELAN | 180 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 113 | 1 | 52 | 12 | 146 | 22 | 134 |
| MULT | 35 | 2 | 104 | 9 | 110 | 12 | 73 |
| OTHER | 51 | 1 | 52 | 6 | 73 | 11 | 67 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2867 | 51 | 2659 | 271 | 3300 | 501 | 3048 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 141 | 1 | 52 | 15 | 183 | 35 | 213 |
| ERLYTX | 11 | 0 | 0 | 3 | 37 | 3 | 18 |
| GU | 6 | 0 | 0 | 3 | 37 | 5 | 30 |
| LEUK | 616 | 12 | 626 | 52 | 633 | 101 | 615 |
| LUNG | 366 | 6 | 313 | 39 | 475 | 76 | 463 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 35 | 1 | 52 | 3 | 37 | 3 | 18 |
| PEOLC | 118 | 1 | 52 | 1 | 12 | 8 | 49 |
| PREV | 216 | 7 | 365 | 21 | 256 | 33 | 201 |
| SXQOL | 593 | 12 | 626 | 64 | 779 | 128 | 779 |
| Total | 2103 | 40 | 2086 | 202 | 2461 | 393 | 2392 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 1122 | 27 | 1409 | 123 | 1498 | 221 | 1345 |
| CCD | 141 | 1 | 52 | 15 | 183 | 35 | 213 |
| ERLYTX | 88 | 2 | 104 | 12 | 146 | 19 | 116 |
| GI | 184 | 2 | 104 | 14 | 170 | 28 | 170 |
| GU | 377 | 5 | 261 | 22 | 268 | 55 | 335 |
| LEUK | 756 | 14 | 730 | 67 | 816 | 124 | 755 |
| LUNG | 565 | 8 | 417 | 64 | 779 | 120 | 731 |
| LYMPH | 394 | 7 | 365 | 40 | 487 | 75 | 457 |
| MELAN | 180 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 113 | 1 | 52 | 12 | 146 | 22 | 134 |
| MULT | 35 | 2 | 104 | 9 | 110 | 12 | 73 |
| OTHER | 86 | 2 | 104 | 9 | 110 | 14 | 85 |
| PEOLC | 118 | 1 | 52 | 1 | 12 | 8 | 49 |
| PREV | 216 | 7 | 365 | 21 | 256 | 33 | 201 |
| SXQOL | 595 | 12 | 626 | 64 | 779 | 128 | 779 |
| Total | 4970 | 91 | 4745 | 473 | 5760 | 894 | 5443 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 716 | 17 | 887 | 72 | 877 | 134 | 816 |
| ERLYTX | 44 | 2 | 104 | 6 | 73 | 10 | 61 |
| GI | 134 | 1 | 52 | 12 | 146 | 23 | 140 |
| GU | 299 | 3 | 157 | 15 | 183 | 37 | 225 |
| LEUK | 85 | 0 | 0 | 9 | 110 | 14 | 85 |
| LUNG | 127 | 0 | 0 | 15 | 183 | 29 | 177 |
| LYMPH | 260 | 5 | 261 | 27 | 329 | 53 | 323 |
| MELAN | 116 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 68 | 0 | 0 | 7 | 85 | 15 | 91 |
| MULT | 15 | 2 | 104 | 5 | 61 | 7 | 43 |
| OTHER | 51 | 1 | 52 | 6 | 73 | 11 | 67 |
| SXQOL | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1917 | 31 | 1617 | 174 | 2120 | 333 | 2028 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| CCD | 120 | 1 | 52 | 10 | 122 | 29 | 177 |
| ERLYTX | 11 | 0 | 0 | 3 | 37 | 3 | 18 |
| GU | 6 | 0 | 0 | 3 | 37 | 5 | 30 |
| LEUK | 270 | 5 | 261 | 27 | 329 | 47 | 286 |
| LUNG | 225 | 4 | 209 | 20 | 244 | 42 | 256 |
| LYMPH | 1 | 0 | 0 | 1 | 12 | 1 | 6 |
| OTHER | 35 | 1 | 52 | 3 | 37 | 3 | 18 |
| PEOLC | 85 | 1 | 52 | 1 | 12 | 6 | 37 |
| PREV | 215 | 6 | 313 | 20 | 244 | 32 | 195 |
| SXQOL | 418 | 10 | 522 | 50 | 609 | 99 | 603 |
| Total | 1386 | 28 | 1461 | 138 | 1683 | 267 | 1626 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 896 | 18 | 939 | 81 | 986 | 161 | 980 |
| CCD | 152 | 3 | 157 | 21 | 256 | 38 | 231 |
| ERLYTX | 55 | 2 | 104 | 9 | 110 | 13 | 79 |
| GI | 140 | 1 | 52 | 13 | 158 | 26 | 158 |
| GU | 338 | 3 | 157 | 27 | 329 | 52 | 317 |
| LEUK | 356 | 5 | 261 | 36 | 438 | 62 | 377 |
| LUNG | 365 | 7 | 365 | 40 | 487 | 78 | 475 |
| LYMPH | 261 | 5 | 261 | 28 | 341 | 54 | 329 |
| MELAN | 116 | 0 | 0 | 0 | 0 | 0 | 0 |
| MMYEL | 67 | 0 | 0 | 7 | 85 | 15 | 91 |
| MULT | 37 | 0 | 0 | 3 | 37 | 9 | 55 |
| OTHER | 234 | 2 | 104 | 20 | 244 | 34 | 207 |
| PEOLC | 82 | 0 | 0 | 1 | 12 | 6 | 37 |
| PREV | 215 | 6 | 313 | 20 | 244 | 32 | 195 |
| SXQOL | 420 | 10 | 522 | 50 | 609 | 99 | 603 |
| Total | 3734 | 62 | 3235 | 356 | 4336 | 679 | 4134 |
| COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| BREAST | 940 | 26 | 1357 | 115 | 1400 | 200 | 1218 |
| ERLYTX | 71 | 2 | 104 | 6 | 73 | 13 | 79 |
| GI | 107 | 1 | 52 | 8 | 97 | 16 | 97 |
| GU | 231 | 5 | 261 | 13 | 158 | 34 | 207 |
| LEUK | 107 | 0 | 0 | 12 | 146 | 19 | 116 |
| LUNG | 164 | 2 | 104 | 23 | 280 | 39 | 237 |
| LYMPH | 323 | 6 | 313 | 32 | 390 | 60 | 365 |
| MMYEL | 100 | 1 | 52 | 11 | 134 | 20 | 122 |
| MULT | 35 | 2 | 104 | 9 | 110 | 12 | 73 |
| Total | 2078 | 45 | 2347 | 229 | 2788 | 413 | 2514 |
| Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
|---|---|---|---|---|---|---|---|
| Member | 1937 | 38 | 1983 | 182 | 2216 | 347 | 2112 |
| AFFIL | 138 | 1 | 52 | 12 | 146 | 16 | 97 |
| CCOP/NCORP | 1228 | 20 | 1044 | 118 | 1437 | 237 | 1443 |
| Non-SWOG | 1664 | 29 | 1513 | 158 | 1924 | 291 | 1771 |
| Total | 4967 | 88 | 4592 | 470 | 5723 | 891 | 5423 |
| ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
|---|---|---|---|---|---|
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 0 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 1 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 2 | E | 26-MAR-26 |
| LEUK | EA9181 | ALL, BCR-ABL+, Steroids+TKI+CT/Blinatumomab | 3 | E | 26-MAR-26 |
| GU | NRGGU011 | Pros, Dbl Blinded RT +/- Androgen Dep Tx | 1 | E | 25-MAR-26 |
| OTHER | NRGGY022 | Mult Site/Stg, Carboplat Clearance Predict | 1 | E | 23-MAR-26 |
| LUNG | EA5231 | Lung, Stg II-IIIB, CheckBlock | 0 | E | 20-MAR-26 |
| LUNG | EA5231 | Lung, Stg II-IIIB, CheckBlock | 1 | E | 20-MAR-26 |
| OTHER | NRGCC014 | High Risk, Bone Meta, Radiation Tx | 1 | E | 20-MAR-26 |
| PEOLC | S2408 | Panc Fistula Prevention, Lanreotide | 1 | T | 16-MAR-26 |
| GU | S1937 | Blad, Mets, Eribulin + Gem vs SOC | 1 | T | 13-MAR-26 |
| SXQOL | A222004 | Mult, Olanza vs Megestrol for Anorexia | 1 | E | 13-MAR-26 |
| SXQOL | EAQ211 | Lymph, Survivors, Health Disp. AYA | 1 | E | 12-MAR-26 |
| BREAST | NRGBR007 | Breast, Stg I, De-Escalation of Breast RT | 1 | E | 08-APR-26 |
| BREAST | NRGBR007 | Breast, Stg I, De-Escalation of Breast RT | 2 | E | 08-APR-26 |
| ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
|---|---|---|---|---|
| BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 21 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 12 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 7 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
| LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 2 | 6 |
| SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
| PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 5 |
| LUNG | LUNGMAP | NSCLC, Adv, Master | 2 | 5 |
| BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 5 |
| LYMPH | S2114 | NHL, Rel/Ref, CD19 CAR-T +/- Consolidation | 1 | 4 |
| LUNG | S2409 | ESCLC, Durvalumab +/- Biomarker Directed Tx | 1 | 4 |
| SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |